QurAlis' Seed VC Round

QurAlis raised a round of funding on April 05, 2018.

QurAlis is a Cambridge-based biotech company that develops precision therapies for ALS patients. QurAlis is developing three precision therapies targeting three distinct subtypes of ALS: a drug to res…

Articles about QurAlis' Seed VC Round: